|
| spouse = | partner = | children = | signature = | signature_alt = | website = | footnotes = }} Sir Salvador Moncada, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently the Director of the Institute of Cancer Sciences at the University of Manchester.〔http://www.manchester.ac.uk/discover/news/article/?id=11902〕 In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained notoriety for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine. 〔Eldridge, S. (“Paper prizes” ). The Guardian, Tuesday 20 November 2001〕〔(Times Higher Education 29 April 2005 interview with Anna Fazackerley )〕〔Roberto Valencia (2007) Inicio platicando. (“Una vida útil (El perfil de un centroamericano de otro mundo: Salvador Moncada)” )〕 ==Early life and education== Moncada was born in Tegucigalpa, Honduras to Salvador Moncada and Jenny Seidner on December 3, 1944 but moved to El Salvador in 1948. He studied medicine at the Facultad de Medicina, Universidad de El Salvador from 1962 to 1970. In 1971 he went to London to work on a PhD with John Vane in the Department of Pharmacology in the Institute of Basic Medical Sciences, Royal College of Surgeons. After a short period of research in the University of Honduras he moved to the Wellcome Research Laboratories (Beckenham, Kent), where he became Director of Research in 1986. In 1996 he moved to University College London where he set up the Wolfson Institute for Biomedical Research in the Cruciform Building, which he directed until 2012. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Salvador Moncada」の詳細全文を読む スポンサード リンク
|